Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SAN DIEGO, Feb. 09, 2016 -- SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment of Laurent Combredet as President and Chief Executive Officer.
"Laurent is a well respected and strategic leader in the aesthetics dermatology field and we are excited to leverage his leadership and experience to help take the company to the next level," said Faheem Hasnain, Chairman of the Board of Directors of SENTÉ. "Laurent is a tremendous addition to SENTÉ and I look forward to his strategic insight as we further position the company to be a major contender in the aesthetics industry.”
Mr. Combredet brings to SENTÉ nearly 20 years of commercial, operations and management experience in the dermatology and consumer products industry. Most recently, Mr. Combredet was General Manager at Allergan, Medical Dermatology and Skin Care Division (including the Skinmedica line of products), where he was responsible for the management of a $700M medical grade skin care business including international operations. Previous to Allergan, Mr. Combredet was Senior Category Leader, Health and Beauty for Amazon France where he held general management positions and full P&L ownership. Mr. Combredet has also held senior commercial and marketing roles with Johnson & Johnson, Neutrogena, Gap and Clairol. He holds a Bachelor of Arts degree from George Washington University and a Masters of Business Administration from Columbia Business School.
"I am thrilled and honored to be joining SENTÉ, a company with deep experience in biotechnology that is pioneering innovative science-based skin care products with proven patient benefits,” said Mr. Combredet, President and Chief Executive Officer of SENTÉ.
About SENTÉ:
SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted medical skincare products based on glycosaminoglycans. Founded in 2007 and based in San Diego, California, further information may be found at http://sentelabs.com/. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
Media Contact: Creative Media Marketing Danielle Hale [email protected] p: 212.979.8884 ext. 213
